Serum apolipoproteins A and B, lecithin:cholesterol acyl transferase activities and urinary cholesterol levels in nephrotic syndrome patients before and during steroid treatment

S. S. Nayak, N. Bhaskaranand, K. S. Kamath, M. Baliga, A. Venkatesh, A. R. Aroor

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Serum apolipoproteins A (Apo-A) and B (Apo-B) and lecithin:cholesterol acyl transferase (LCAT) activities and 24-hour urinary cholesterol levels were estimated in 25 nephrotic children before and during steroid treatment with 4 weeks of daily prednisolone followed by another 4 weeks of alternate-day prednisolone. The patients with untreated nephrotic syndrome (NS) showed significant decrease in serum Apo-A and LCAT activities associated with significant increase in serum Apo-B and urinary cholesterol levels compared to healthy controls (n = 25). Serum Apo-A levels correlated directly and Apo-B levels inversely with the serum albumin concentrations. After a transient elevation, the serum Apo-A level returned to control range by 8 weeks of treatment accompanied by a gradual increase in serum LCAT activity and decrease in urinary cholesterol excretion. Though, the serum Apo-b level was decreased with treatment, it was still significantly high compared to the controls.

Original languageEnglish
Pages (from-to)234-239
Number of pages6
JournalNephron
Volume54
Issue number3
Publication statusPublished - 01-01-1990

Fingerprint

Apolipoproteins A
Lecithins
Apolipoproteins B
Nephrotic Syndrome
Transferases
Steroids
Cholesterol
Serum
Prednisolone
Therapeutics
Serum Albumin

All Science Journal Classification (ASJC) codes

  • Physiology
  • Nephrology
  • Urology
  • Physiology (medical)

Cite this

@article{96c9db85147042708835fd2b4d7af36e,
title = "Serum apolipoproteins A and B, lecithin:cholesterol acyl transferase activities and urinary cholesterol levels in nephrotic syndrome patients before and during steroid treatment",
abstract = "Serum apolipoproteins A (Apo-A) and B (Apo-B) and lecithin:cholesterol acyl transferase (LCAT) activities and 24-hour urinary cholesterol levels were estimated in 25 nephrotic children before and during steroid treatment with 4 weeks of daily prednisolone followed by another 4 weeks of alternate-day prednisolone. The patients with untreated nephrotic syndrome (NS) showed significant decrease in serum Apo-A and LCAT activities associated with significant increase in serum Apo-B and urinary cholesterol levels compared to healthy controls (n = 25). Serum Apo-A levels correlated directly and Apo-B levels inversely with the serum albumin concentrations. After a transient elevation, the serum Apo-A level returned to control range by 8 weeks of treatment accompanied by a gradual increase in serum LCAT activity and decrease in urinary cholesterol excretion. Though, the serum Apo-b level was decreased with treatment, it was still significantly high compared to the controls.",
author = "Nayak, {S. S.} and N. Bhaskaranand and Kamath, {K. S.} and M. Baliga and A. Venkatesh and Aroor, {A. R.}",
year = "1990",
month = "1",
day = "1",
language = "English",
volume = "54",
pages = "234--239",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "3",

}

Serum apolipoproteins A and B, lecithin:cholesterol acyl transferase activities and urinary cholesterol levels in nephrotic syndrome patients before and during steroid treatment. / Nayak, S. S.; Bhaskaranand, N.; Kamath, K. S.; Baliga, M.; Venkatesh, A.; Aroor, A. R.

In: Nephron, Vol. 54, No. 3, 01.01.1990, p. 234-239.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum apolipoproteins A and B, lecithin:cholesterol acyl transferase activities and urinary cholesterol levels in nephrotic syndrome patients before and during steroid treatment

AU - Nayak, S. S.

AU - Bhaskaranand, N.

AU - Kamath, K. S.

AU - Baliga, M.

AU - Venkatesh, A.

AU - Aroor, A. R.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Serum apolipoproteins A (Apo-A) and B (Apo-B) and lecithin:cholesterol acyl transferase (LCAT) activities and 24-hour urinary cholesterol levels were estimated in 25 nephrotic children before and during steroid treatment with 4 weeks of daily prednisolone followed by another 4 weeks of alternate-day prednisolone. The patients with untreated nephrotic syndrome (NS) showed significant decrease in serum Apo-A and LCAT activities associated with significant increase in serum Apo-B and urinary cholesterol levels compared to healthy controls (n = 25). Serum Apo-A levels correlated directly and Apo-B levels inversely with the serum albumin concentrations. After a transient elevation, the serum Apo-A level returned to control range by 8 weeks of treatment accompanied by a gradual increase in serum LCAT activity and decrease in urinary cholesterol excretion. Though, the serum Apo-b level was decreased with treatment, it was still significantly high compared to the controls.

AB - Serum apolipoproteins A (Apo-A) and B (Apo-B) and lecithin:cholesterol acyl transferase (LCAT) activities and 24-hour urinary cholesterol levels were estimated in 25 nephrotic children before and during steroid treatment with 4 weeks of daily prednisolone followed by another 4 weeks of alternate-day prednisolone. The patients with untreated nephrotic syndrome (NS) showed significant decrease in serum Apo-A and LCAT activities associated with significant increase in serum Apo-B and urinary cholesterol levels compared to healthy controls (n = 25). Serum Apo-A levels correlated directly and Apo-B levels inversely with the serum albumin concentrations. After a transient elevation, the serum Apo-A level returned to control range by 8 weeks of treatment accompanied by a gradual increase in serum LCAT activity and decrease in urinary cholesterol excretion. Though, the serum Apo-b level was decreased with treatment, it was still significantly high compared to the controls.

UR - http://www.scopus.com/inward/record.url?scp=0025166368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025166368&partnerID=8YFLogxK

M3 - Article

C2 - 2314540

AN - SCOPUS:0025166368

VL - 54

SP - 234

EP - 239

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

IS - 3

ER -